Abstract
Renal involvement is very common in tuberous sclerosis complex (TSC) and is characterized by the development of angiomyolipoma and cysts. The aims of the present study were to assess kidney function and clinical features of renal involvement in TSC, including kidney function and blood pressure (BP) levels in children, adolescents and young adults. Non-selected patients with a definite diagnosis of TSC attending the paediatric neurology outpatient department of a tertiary hospital were included in a cross-sectional study. All participants had a renal imaging study within 6 months of ambulatory blood pressure (BP) and glomerular filtration rate (GFR) assessment. Data on demographics, history, genotype, kidney function at diagnosis and last imaging were collected. Twenty patients were enrolled in this study with a median age of 15 years (IQR range 9 to 18). About 23.5% of the participants had ambulatory hypertension. Systolic BP levels correlated significantly with GFRDTPA values despite the absence of hyperfiltration. Patients that developed hypertension and possibly those with angiomyolipoma or cysts had higher GFR levels in childhood and adolescence. All the patients with ambulatory hypertension had angiomyolipoma or cysts on renal imaging studies.
Conclusions: Hypertension may present with increased frequency in young patients with kidney disease associated with TSC. Routine ambulatory BP measurement should be part of the annual clinical assessment in patients with TSC.
What is Known: • Nearly half of the patients with TSC have a premature decline in their renal function in their fifth decade of life. • Hypertension and hyperfiltration have been proposed as modifiable factors of progression of renal decline in patients with TSC-related renal disease. | |
What is New: • Hypertension is prevalent in youth with tuberous sclerosis complex. • SBP levels have a positive relation with GFR levels within the normal range of GFRDTPA values. |
Similar content being viewed by others
Availability of data and material
The datasets generated and/or analysed during the current study are available from the corresponding author on reasonable request.
Abbreviations
- ABPM :
-
Ambulatory blood pressure monitoring
- AML :
-
Angiomyolipoma
- BP :
-
Blood pressure
- cSBP :
-
Central systolic blood pressure
- CKD :
-
Chronic kidney disease
- CT :
-
Computed tomography
- DBP :
-
Diastolic blood pressure
- DTPA :
-
Diethylenetriaminepentaacetic acid
- eGFR :
-
Estimated glomerular filtration rate
- EMMS :
-
Estimated marginal means
- GFR :
-
Glomerular filtration rate
- MRI :
-
Magnetic resonance imaging
- mTOR :
-
Mammalian target of rapamycin
- PWV :
-
Pulse wave velocity
- SBP :
-
Systolic blood pressure
- TSC :
-
Tuberous sclerosis complex
- TSC-PKD1 :
-
Tuberous sclerosis complex-polycystic kidney disease 1
- US :
-
Ultrasound
References
Osborne JP, Fryer A, Webb D (1991) Epidemiology of tuberous sclerosis. Annals of the New York Academy of Sciences 615:125–127. https://doi.org/10.1111/j.1749-6632.1991.tb37754.x
van Slegtenhorst M, de Hoogt R, Hermans C et al (1997) Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science 277:805–808. https://doi.org/10.1126/science.277.5327.805
Kandt RS, Haines JL, Smith M et al (1992) Linkage of an important gene locus for tuberous sclerosis to a chromosome 16 marker for polycystic kidney disease. Nat Genet 2:37–41. https://doi.org/10.1038/ng0992-37
The European Chromosome 16 Tuberous Sclerosis Consortium (1993) Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell 75:1305–1315. https://doi.org/10.1016/0092-8674(93)90618-Z
Henske EP, Józwiak S, Kingswood JC et al (2016) Tuberous sclerosis complex. Nature Reviews Disease Primers 2. https://doi.org/10.1038/nrdp.2016.35
Amin S, Lux A, Calder N et al (2017) Causes of mortality in individuals with tuberous sclerosis complex. Dev Med Child Neurol 59:612–617. https://doi.org/10.1111/dmcn.13352
Shepherd CW, Gomez MR, Lie JT, Crowson CS (1991) Causes of death in patients with tuberous sclerosis. Mayo Clin Proc 66:792–796. https://doi.org/10.1016/S0025-6196(12)61196-3
Eijkemans MJC, van der Wal W, Reijnders LJ et al (2015) Long-term follow-up assessing renal angiomyolipoma treatment patterns, morbidity, and mortality: an observational study in tuberous sclerosis complex patients in the Netherlands. Am J Kidney Dis 66. https://doi.org/10.1053/j.ajkd.2015.05.016
Bissler JJ, Christopher Kingswood J (2018) Renal manifestation of tuberous sclerosis complex. Am J Med Genet C Semin Med Genet 178:338–347. https://doi.org/10.1002/ajmg.c.31654
Robertson FM, Cendron M, Klauber GT, Harris BH (1996) Renal cell carcinoma in association with tuberous sclerosis in children. J Pediatr Surg 31. https://doi.org/10.1016/S0022-3468(96)90689-2
Sauter M, Belousova E, Benedik MP et al (2021) Rare manifestations and malignancies in tuberous sclerosis complex: findings from the TuberOus SClerosis registry to increAse disease awareness (TOSCA). Orphanet J Rare Dis 16. https://doi.org/10.1186/s13023-021-01917-y
Janssens P, van Hoeve K, de Waele L et al (2018) Renal progression factors in young patients with tuberous sclerosis complex: a retrospective cohort study. Pediatr Nephrol 33:2085–2093. https://doi.org/10.1007/s00467-018-4003-6
Stevens PE (2013) Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med 158. https://doi.org/10.7326/0003-4819-158-11-201306040-00007
Simonsen JA, Thilsing-Hansen K, Høilund-Carlsen PF et al (2020) Glomerular filtration rate: comparison of simultaneous plasma clearance of 99mTc-DTPA and 51Cr-EDTA revisited. Scand J Clin Lab Invest 80. https://doi.org/10.1080/00365513.2020.1759138
Andersen TB, Jødal L, Nielsen NS, Petersen LJ (2019) Comparison of simultaneous plasma clearance of 99mTc-DTPA and 51Cr-EDTA: can one tracer replace the other? Scand J Clin Lab Invest 79. https://doi.org/10.1080/00365513.2019.1658217
Schwartz GJ, Haycock GB, Edelmann CM Jr, Spitzer A (1976) A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 58:259–263
Jaffe M (1886) Ueber den Niederschlag, welchen Pikrinsäure in normalem Harn erzeugt und über eine neue Reaction des Kreatinins. ZPhysiolChem 10:391–400
Helal I, Fick-Brosnahan GM, Reed-Gitomer B, Schrier RW (2012) Glomerular hyperfiltration: definitions, mechanisms and clinical implications. Nat Rev Nephrol 8. https://doi.org/10.1038/nrneph.2012.19
Lurbe E, Agabiti-Rosei E, Cruickshank JK, et al (2016) 2016 European Society of Hypertension guidelines for the management of high blood pressure in children and adolescents. J Hyperten 34. https://doi.org/10.1097/HJH.0000000000001039
Stabouli S, Papakatsika S, Kotronis G et al (2015) Arterial stiffness and SBP variability in children and adolescents. J Hyperten 33. https://doi.org/10.1097/HJH.0000000000000369
Kotsis V, Stabouli S, Pitiriga V et al (2006) Ambulatory blood pressure monitoring and target organ damage: effects of age and sex. Blood Press Monit 11. https://doi.org/10.1097/01.mbp.0000189785.59994.20
Kollios K, Nika T, Kotsis V et al (2021) Arterial stiffness in children and adolescents with masked and sustained hypertension. J Hum Hyperten 35. https://doi.org/10.1038/s41371-020-0318-4
Flynn JT, Daniels SR, Hayman LL et al (2014) Update: Ambulatory Blood Pressure Monitoring in Children and Adolescents. Hypertension 63. https://doi.org/10.1161/HYP.0000000000000007
Wassertheurer S, Kropf J, Weber T et al (2010) A new oscillometric method for pulse wave analysis: comparison with a common tonometric method. J Hum Hyperten 24. https://doi.org/10.1038/jhh.2010.27
Shiraishi M, Murakami T, Higashi K (2020) The accuracy of central blood pressure obtained by oscillometric noninvasive method using Mobil-O-Graph in children and adolescents. J Hyperten 38. https://doi.org/10.1097/HJH.0000000000002360
Elmenhorst J, Hulpke-Wette M, Barta C et al (2015) Percentiles for central blood pressure and pulse wave velocity in children and adolescents recorded with an oscillometric device. Atherosclerosis 238. https://doi.org/10.1016/j.atherosclerosis.2014.11.005
Vekeman F, Magestro M, Karner P et al (2015) Kidney involvement in tuberous sclerosis complex: the impact on healthcare resource use and costs. J Med Econ 18. https://doi.org/10.3111/13696998.2015.1075995
Kingswood JC, Nasuti P, Patel K et al (2016) The economic burden of tuberous sclerosis complex in UK patients with renal manifestations: a retrospective cohort study in the clinical practice research datalink (CPRD). J Med Econ 19. https://doi.org/10.1080/13696998.2016.1202254
Kingswood JC, Belousova E, Benedik MP et al (2020) Renal manifestations of tuberous sclerosis complex: key findings from the final analysis of the TOSCA study focussing mainly on renal angiomyolipomas. Front Neurol 11. https://doi.org/10.3389/fneur.2020.00972
Malaga-Dieguez L, Spencer R, Pehrson LJ et al (2017) Early manifestations of renal disease in patients with tuberous sclerosis complex. Int J Nephrol Renov Dis 10. https://doi.org/10.2147/IJNRD.S123638
Pan X, Yang C, Ma S et al (2021) A case of TSC2‐PKD1 contiguous deletion syndrome: clinical features and effective treatment for epilepsy. Int J Dev Neurosci. https://doi.org/10.1002/jdn.10088
Brook-Carter PT, Peral B, Ward CJ et al (1994) Deletion of the TSC2 and PKD1 genes associated with severe infantile polycystic kidney disease — a contiguous gene syndrome. Nat Genet 8:328–332. https://doi.org/10.1038/ng1294-328
Sampson JR, Maheshwar MM, Aspinwall R et al (1997) Renal cystic disease in tuberous sclerosis: role of the polycystic kidney disease 1 gene. Am J Hum Genet 61. https://doi.org/10.1086/514888
Sperandio M, Weber L, Jauch A et al (2000) Cutaneous white spots in a child with polycystic kidneys: a clue to TSC2/PKD1 gene mutation. Nephrol Dial Transplant 15. https://doi.org/10.1093/ndt/15.6.909
Laass MW, Spiegel M, Jauch A et al (2004) Tuberous sclerosis and polycystic kidney disease in a 3-month-old infant. Pediatr Nephrol 19. https://doi.org/10.1007/s00467-004-1442-z
el Aoud S, Frikha F, Snoussi M et al (2017) Tuberous sclerosis complex (Bourneville-Pringle disease) in a 25-year-old female with bilateral renal angiomyolipoma and secondary hypertension. Saudi J Kidney Dis Transpl 28. https://doi.org/10.4103/1319-2442.206461
Sarafidis PA, Bikos A, Loutradis C et al (2017) Diagnosis of tuberous sclerosis complex in a patient referred for uncontrolled hypertension and renal dysfunction: a case highlighting the importance of proper diagnostic work-up of hypertensive patients. J Hypertens 35:2109–2114. https://doi.org/10.1097/HJH.0000000000001423
Emad Momtaz H (2010) Tuberous sclerosis with hypertension and abdominal pain in a child. Iran J Kidney Dis 4:253–258
Wong H, Hadi M, Khoury T et al (2006) Management of severe hypertension in a child with tuberous sclerosis-related major vascular abnormalities. J Hyperten 24. https://doi.org/10.1097/01.hjh.0000209994.33680.11
Nass RD, Hampel KG, Elger CE, Surges R (2019) Blood pressure in seizures and epilepsy. Front Neurol 10. https://doi.org/10.3389/fneur.2019.00501
Kingswood JC, Bissler JJ, Budde K et al (2016) Review of the tuberous sclerosis renal guidelines from the 2012 Consensus Conference: current data and future study. Nephron 134:51–58. https://doi.org/10.1159/000448293
Warncke JC, Brodie KE, Grantham EC et al (2017) Pediatric renal angiomyolipomas in tuberous sclerosis complex. J Urol 197:500–506. https://doi.org/10.1016/j.juro.2016.09.082
Bissler JJ, Kingswood JC, Radzikowska E et al (2013) Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial. The Lancet 381:817–824. https://doi.org/10.1016/S0140-6736(12)61767-X
Author information
Authors and Affiliations
Contributions
EV: approved the final version; SS: designed the study, performed the statistical analysis, interpreted the data, drafted the initial manuscript, revised and approved the final version; CS: performed the data collection, interpretation of the data, edited the initial manuscript and approved the final draft; MK: approved the final draft; AA: approved the final draft; AN: edited and approved the final draft; DZ: revised and approved the final version.
Corresponding author
Ethics declarations
Ethics approval
This study was approved by the Ethics Committee of the Aristotle University of Thessaloniki and was conducted in accordance with the 1964 Helsinki Declaration standards.
Consent to participate
Informed consent was obtained from the parents of all the participants.
Consent for publication
All the authors have read and approved the paper and have met the criteria for authorship as established by the International Committee of Medical Journals Editors.
Conflict of interest
DZ has received honoraria, travel and research grants from Novartis and Pharmaten. EV has received travel grants from Novartis. SS, CS, MK, AA and AN declare that they have no financial interests. DZ has served on advisory boards for Novartis and Pharmaten. EV, SS, CS, MK, AA and AN declare that they have no non-financial interests.
Additional information
Communicated by Gregorio Paolo Milani
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Vargiami, E., Stabouli, S., Sidira, C. et al. Blood pressure and glomerular filtration rate in youth with tuberous sclerosis complex. Eur J Pediatr 181, 1465–1472 (2022). https://doi.org/10.1007/s00431-021-04333-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00431-021-04333-3